Tokyo, Japan

Takahiro Nagayama

USPTO Granted Patents = 11 


 

Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2000-2024

where 'Filed Patents' based on already Granted Patents

11 patents (USPTO):

Title: Takahiro Nagayama: Innovator in Pharmaceutical Chemistry

Introduction

Takahiro Nagayama is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for treating various diseases. With a total of 11 patents to his name, his work has the potential to impact the medical community significantly.

Latest Patents

One of his latest patents involves azole derivatives as apelin receptor agonists. This invention relates to a novel azole derivative that can be used in methods for treating cardiovascular diseases, diabetic diseases, renal diseases, hypertension, and arteriosclerosis. The patent provides a compound represented by a specific formula, which includes various groups that enhance its pharmacological properties.

Career Highlights

Throughout his career, Takahiro has worked with notable companies such as Nippon Chemical Industrial Co., Ltd. and Sanford Burnham Prebys Medical Discovery Institute. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical sector.

Collaborations

Takahiro has collaborated with esteemed colleagues, including Yutaka Kinose and Takuya Ikeda. These partnerships have fostered an environment of innovation and creativity, leading to the development of impactful inventions.

Conclusion

Takahiro Nagayama's work exemplifies the spirit of innovation in pharmaceutical chemistry. His contributions through patents and collaborations continue to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…